SENSEX NIFTY

Pharma

May 22, 2015 at 21:14 | Source: PTI
Total income also rose to Rs 825.27 crore during last fiscal from Rs 738.89 crore in the previous financial year.
May 22, 2015 at 13:44 | Source: CNBC-TV18
Aditya Agarwal of Way2wealth Securities recommends going long in Sun Pharmaceutical Industries and Larsen & Toubro.
May 22, 2015 at 13:00 | Source: Moneycontrol.com
SBI is up 3 percent while Sun Pharma, HDFC, TCS and ONGC are top gainers in the Sensex. Among the losers are Bajaj Auto, Wipro, Vedanta, Hindalco and Hero Motocorp.
May 22, 2015 at 12:00 | Source: Moneycontrol.com
FM said minimum alternate tax (MAT) issue will be resolved through judicial process and the government will take all efforts to meet the April 1, 2016 deadline for GST. He added that 'simplification of tax policies is our objective.'
May 22, 2015 at 09:56 | Source: Moneycontrol.com
According to Ambit analysts Gaurav Mehta and Prashant Mittal, the Niftys intermediate trend is down as it continues to trade below the key trendline that had defined the upmove on the index since the May 2014 elections
May 22, 2015 at 09:26 | Source: CNBC-TV18
Rajat Bose of rajatkbose.com recommends buying ACC and advises looking at Sun Pharmaceutical Industries and Coal India.
May 21, 2015 at 14:41 | Source: Moneycontrol.com
Tata Steel ended with 5 percent loss. Vedanta fell 3 percent while Cipla, ICICI Bank and ITC were major laggards. Bajaj Auto was up 7 percent while Coal India, Axis Bank, L&T and HUL were gainers.
May 21, 2015 at 13:35 | Source: Moneycontrol.com
Anuh Pharma has informed that a meeting of the Board of Directors of the Company will be held on May 29, 2015, to consider and approve the Audited Financial Results of the Company for the financial year ended March 31, 2015 and to recommend final Dividend, if any, for the financial year 2014-15.
May 21, 2015 at 13:02 | Source: CNBC-TV18
The new business will operate under Arrow Pharma and sell 140 generic drugs. The transaction will be financed by internal accruals and debt financing. The acquisition will be EPS accretive immediately.
May 21, 2015 at 12:32 | Source: PTI
Lennox-Gastaut syndrome is a form of childhood-onset epilepsy. "Glenmark has been granted tentative approval last week by the United States Food and Drug Administration (USFDA) for its Rufinamide tablets," the company said in a BSE filing.
Messages on Pharma »

subs74

Silver Member

4 Followers

Biocon  

Namo baba, at the end of the day its about fundamentals as also whether stock is in strong hands. pls look at other midcap pharma stocks like cadila, zydus,ipca. They have all gone up even on such a day despite having run up already which means they are in strong hands who dont allow the stocks

4.54 PM Jul 8th 2014

abhishek_co
ssipore

New Member

1 Followers

Dishman Pharma  

Hold Dishman Pharma Targe Price 205

4.48 PM Jul 8th 2014

subs74

Silver Member

4 Followers

Biocon  

I can understand a minor correction due to market sentiment but a 7% fall in a pharma stock like Biocon on the day of railway budget with which it has no correlation is strange. Either the correction is silly or the upmove itself in Biocon was not based on any fundamentals.

4.33 PM Jul 8th 2014

Ajanta Pharma  

After AGM the share price will shoot up towards benefits to all investers - My target for Ajanta Pharma is Rs 2500 for the long term with a stoploss of Rs 1499

4.30 PM Jul 8th 2014

Ravi_jangra

New Member

0 Follower

Alembic Pharma  

Salute to alembic pharma....All stocks down but alembic not....Guys today see alembic strong unbreakable resistance on 300/-.This is righttime to entre now or never...Save me today from huge lose

4.19 PM Jul 8th 2014

jagoinvesto
r

Platinum Member

122 Followers

Morepen Lab  

morepen to buy sun pharma

4.15 PM Jul 8th 2014

JPInvestor

New Member

1 Followers

SMS Pharma  

my view is that the equity base of SMS Pharma is very small and already having good profit. hence it can easily cross the above figures.

3.55 PM Jul 8th 2014

subs74

Silver Member

4 Followers

Biocon  

How does budget affect pharma stocks like biocon?

3.47 PM Jul 8th 2014

shmarketgen
ius

Platinum Member

674 Followers

Tech Mahindra  

suggest,that you try & find a small/mid- cap Pharma/IT/Auto Ancillary company or a consumer play.These stories are huuuge in size & will pay rich dividends.

3.47 PM Jul 8th 2014

countryman

Platinum Member

837 Followers

Granules India  

For solving the problem of CAD, Re cannot go down so much to probably 53 levels which will hurt the exporters. I understand that RBI will control Re between 58 to 61 level so that exporters will get benefitted. Company has expanded their facilities, bought Auctus Pharma and this year Auctus

3.36 PM Jul 8th 2014

News across the web »
May 22, 2015 at 12:44 | Source: FirstPost
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.